These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26382057)

  • 1. Reduced expression of membrane-bound (m)RAGE is a biomarker of multiple sclerosis disease progression.
    Sternberg Z; Chiotti A; Tario J; Chichelli T; Patel N; Chadha K; Yu J; Karmon Y
    Immunobiology; 2016 Feb; 221(2):193-8. PubMed ID: 26382057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of RAGE splicing by hnRNP A1 and Tra2β-1 and its potential role in AD pathogenesis.
    Liu XY; Li HL; Su JB; Ding FH; Zhao JJ; Chai F; Li YX; Cui SC; Sun FY; Wu ZY; Xu P; Chen XH
    J Neurochem; 2015 Apr; 133(2):187-98. PubMed ID: 25689357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease modifying drugs modulate endogenous secretory receptor for advanced glycation end-products, a new biomarker of clinical relapse in multiple sclerosis.
    Sternberg Z; Sternberg D; Drake A; Chichelli T; Yu J; Hojnacki D
    J Neuroimmunol; 2014 Sep; 274(1-2):197-201. PubMed ID: 25064498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fingolimod anti-inflammatory and neuroprotective effects modulation of RAGE axis in multiple sclerosis patients.
    Sternberg Z; Kolb C; Chadha K; Nir A; Nir R; George R; Johnson J; Yu J; Hojnacki D
    Neuropharmacology; 2018 Mar; 130():71-76. PubMed ID: 29197515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease.
    Mahajan N; Malik N; Bahl A; Dhawan V
    Atherosclerosis; 2009 Dec; 207(2):597-602. PubMed ID: 19576587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced expression of receptor for advanced glycation end products in chronic kidney disease.
    Hou FF; Ren H; Owen WF; Guo ZJ; Chen PY; Schmidt AM; Miyata T; Zhang X
    J Am Soc Nephrol; 2004 Jul; 15(7):1889-96. PubMed ID: 15213278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activation of receptor for advanced glycation end products: a mechanism for monocyte-mediated inflammation in chronic renal failure].
    Hou FF; Ren H; Guo ZJ; Chen PY; Liang M; Zhang X
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1614-9. PubMed ID: 15569456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble Receptor for Advanced Glycation End Products (sRAGE) is Up-Regulated in Multiple Sclerosis Patients Treated with Interferon β-1a.
    Rahimi M; Aghabozorg Afjeh SS; Omrani MD; Arsang-Jang S; Ganji M; Noroozi R; Taheri M; Ghafouri-Fard S
    Cell Physiol Biochem; 2018; 46(2):561-567. PubMed ID: 29617694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAGE gene polymorphisms in patients with multiple sclerosis.
    Tiszlavicz Z; Gyulai Z; Bencsik K; Szolnoki Z; Kocsis AK; Somogyvári F; Vécsei L; Mándi Y
    J Mol Neurosci; 2009 Nov; 39(3):360-5. PubMed ID: 19757202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-mobility group box 1 in multiple sclerosis.
    Sternberg Z; Sternberg D; Chichelli T; Drake A; Patel N; Kolb C; Chadha K; Yu J; Hojnacki D
    Immunol Res; 2016 Apr; 64(2):385-91. PubMed ID: 26100980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Mouse-Specific Splice Variant mRAGE_v4 Encodes a Membrane-Bound RAGE That Is Resistant to Shedding and Does Not Contribute to the Production of Soluble RAGE.
    Di Maggio S; Gatti E; Liu J; Bertolotti M; Fritz G; Bianchi ME; Raucci A
    PLoS One; 2016; 11(9):e0153832. PubMed ID: 27655137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressors of cytokine signalling in ankylosing spondylitis and their associations with disease severity, acute-phase reactants and serum cytokines.
    Chen CH; Chen HA; Liao HT; Liu CH; Tsai CY; Chou CT
    Clin Exp Rheumatol; 2016; 34(1):100-5. PubMed ID: 26812031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E genotype does not associate with disease severity measured by Multiple Sclerosis Severity Score.
    Guerrero AL; Laherrán E; Gutiérrez F; Martín-Polo J; Iglesias F; Alcázar C; Peralta J; Rostami P
    Acta Neurol Scand; 2008 Jan; 117(1):21-5. PubMed ID: 17883422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arylsulfatase a gene polymorphisms in relapsing remitting multiple sclerosis: genotype-phenotype correlation and estimation of disease progression.
    Baronica KB; Mlinac K; Ozretić D; Vladić A; Bognar SK
    Coll Antropol; 2011 Jan; 35 Suppl 1():11-6. PubMed ID: 21648305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-β 1a Modulates Expression of RAGE but Not S100A12 and Nuclear Factor-κB in Multiple Sclerosis Patients.
    Asadikaram G; Noroozi S; Ebrahimi Meimand HA; Sanjari M; Zainodini N; Khoramdelazad H; Shahrokhi N; Kazemi Arababadi M
    Neuroimmunomodulation; 2016; 23(5-6):345-351. PubMed ID: 28433998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental expression of the receptor for advanced glycation end-products (RAGE) and its response to hyperoxia in the neonatal rat lung.
    Lizotte PP; Hanford LE; Enghild JJ; Nozik-Grayck E; Giles BL; Oury TD
    BMC Dev Biol; 2007 Mar; 7():15. PubMed ID: 17343756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum NSE level and disability progression in multiple sclerosis.
    Koch MW; George S; Wall W; Wee Yong V; Metz LM
    J Neurol Sci; 2015 Mar; 350(1-2):46-50. PubMed ID: 25686504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Piperi C; Kalofoutis A; Creatsas G
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):37-43. PubMed ID: 15638868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIGLEC1 and SIGLEC7 expression in circulating monocytes of patients with multiple sclerosis.
    Malhotra S; Castilló J; Bustamante M; Vidal-Jordana A; Castro Z; Montalban X; Comabella M
    Mult Scler; 2013 Apr; 19(5):524-31. PubMed ID: 22933622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary advanced glycated end-products and medicines influence the expression of SIRT1 and DDOST in peripheral mononuclear cells from long-term type 1 diabetes patients.
    Santos-Bezerra DP; Machado-Lima A; Monteiro MB; Admoni SN; Perez RV; Machado CG; Shimizu MH; Cavaleiro AM; Thieme K; Queiroz MS; Machado UF; Giannella-Neto D; Passarelli M; Corrêa-Giannella ML
    Diab Vasc Dis Res; 2018 Jan; 15(1):81-89. PubMed ID: 29027826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.